BIOMAT Database Logo BIOMAT Database Logo

Immune thrombocytopenia in severe hemophilia A treated with high-dose intravenous immunoglobulin. 1986

S Panzer, and U Zeitelhuber, and V Hach, and H H Brackmann, and H Niessner, and C Mueller-Eckhardt

Five patients with severe hemophilia A receiving long-term treatment with commercial factor VIII concentrates developed severe immune thrombocytopenia (ITP, platelet counts less than 20 X 10(9)/l). Concomitantly, they presented with a marked elevation of serum IgG concentrations (mean, 2364 mg/dl;range, 1712-2954 mg/dl). In four patients, the T helper to suppressor cell ratio was below 1. Treatment with high-dose intravenous immunoglobulin (IgG, 7s) at doses of 0.2g (n = 2) or 0.4g (n = 3) per kg of body weight on 5 consecutive days was effective immediately. The bleeding tendency ceased and platelet counts rose transiently. In three cases, treatment was repeatedly effective and patients underwent uneventful splenectomies. Thus, high-dose IgG therapy may serve as a life-saving agent in patients with severe hemophilia complicated by ITP.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D008297 Male Males
D010976 Platelet Count The number of PLATELETS per unit volume in a sample of venous BLOOD. Blood Platelet Count,Blood Platelet Number,Platelet Number,Blood Platelet Counts,Blood Platelet Numbers,Count, Blood Platelet,Count, Platelet,Counts, Blood Platelet,Counts, Platelet,Number, Blood Platelet,Number, Platelet,Numbers, Blood Platelet,Numbers, Platelet,Platelet Count, Blood,Platelet Counts,Platelet Counts, Blood,Platelet Number, Blood,Platelet Numbers,Platelet Numbers, Blood
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005169 Factor VIII Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin. Coagulation Factor VIII,Factor VIII Clotting Antigen,Factor VIII Coagulant Antigen,Factor VIII Procoagulant Activity,Thromboplastinogen,Blood Coagulation Factor VIII,F VIII-C,Factor 8,Factor 8 C,Factor Eight,Factor VIIIC,Hyate-C,Hyatt-C,F VIII C,Hyate C,HyateC,Hyatt C,HyattC
D006467 Hemophilia A The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage. Factor VIII Deficiency,Hemophilia,Autosomal Hemophilia A,Classic Hemophilia,Deficiency, Factor VIII,Factor 8 Deficiency, Congenital,Factor VIII Deficiency, Congenital,Haemophilia,Hemophilia A, Congenital,Hemophilia, Classic,As, Autosomal Hemophilia,Autosomal Hemophilia As,Classic Hemophilias,Congenital Hemophilia A,Congenital Hemophilia As,Hemophilia A, Autosomal,Hemophilia As,Hemophilia As, Autosomal,Hemophilia As, Congenital,Hemophilias, Classic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

S Panzer, and U Zeitelhuber, and V Hach, and H H Brackmann, and H Niessner, and C Mueller-Eckhardt
[Cyclic thrombocytopenia treated by high-dose intravenous immunoglobulin with a favorable response].
May 1988, [Rinsho ketsueki] The Japanese journal of clinical hematology,
S Panzer, and U Zeitelhuber, and V Hach, and H H Brackmann, and H Niessner, and C Mueller-Eckhardt
[Thrombocytopenia in a patient with hemophilia and HIV infection treated with intravenous immunoglobulin and splenectomy].
January 1989, Przeglad dermatologiczny,
S Panzer, and U Zeitelhuber, and V Hach, and H H Brackmann, and H Niessner, and C Mueller-Eckhardt
High-dose intravenous immunoglobulin and splenectomy for the treatment of HIV-related immune thrombocytopenia in patients with severe haemophilia.
March 1988, British journal of haematology,
S Panzer, and U Zeitelhuber, and V Hach, and H H Brackmann, and H Niessner, and C Mueller-Eckhardt
Intravenous immunoglobulin in immune thrombocytopenia.
September 1983, Lancet (London, England),
S Panzer, and U Zeitelhuber, and V Hach, and H H Brackmann, and H Niessner, and C Mueller-Eckhardt
Yersinia enterocolitica infection complicated by severe thrombocytopenia resistant to high-dose intravenous immunoglobulin.
January 1985, Acta medica Scandinavica,
S Panzer, and U Zeitelhuber, and V Hach, and H H Brackmann, and H Niessner, and C Mueller-Eckhardt
Use of intravenous immunoglobulin in severe refractory idiopathic immune thrombocytopenia.
October 1987, Journal of the Royal Society of Medicine,
S Panzer, and U Zeitelhuber, and V Hach, and H H Brackmann, and H Niessner, and C Mueller-Eckhardt
Co-incidental Von Willebrands disease and immune thrombocytopenia in pregnancy: treatment with high dose intravenous immunoglobulin.
January 1986, Clinical and laboratory haematology,
S Panzer, and U Zeitelhuber, and V Hach, and H H Brackmann, and H Niessner, and C Mueller-Eckhardt
Severe Refractory Immune Thrombocytopenia Successfully Treated with High-Dose Pulse Cyclophosphamide and Eltrombopag.
January 2015, Case reports in hematology,
S Panzer, and U Zeitelhuber, and V Hach, and H H Brackmann, and H Niessner, and C Mueller-Eckhardt
Fondaparinux cross-reactivity in heparin-induced thrombocytopenia successfully treated with high-dose intravenous immunoglobulin and rivaroxaban.
January 2020, Platelets,
S Panzer, and U Zeitelhuber, and V Hach, and H H Brackmann, and H Niessner, and C Mueller-Eckhardt
Reticuloendothelial system Fc-receptor function in patients with immune thrombocytopenia after treatment with high dose intravenous immunoglobulin.
August 1986, Scandinavian journal of haematology,
Copied contents to your clipboard!